U.S. Food and Drug Administration Approves Two Opdivo® (nivolumab)-Based Regimens as First-Line Treatments for Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Original Source
Business News – Direct Source News
SANTA CLARA, Calif., May 27, 2022 (GLOBE NEWSWIRE) — NVIDIARead More
HOUSTON, May 27, 2022 /PRNewswire/ — Quanta Services, Inc. (NYSE:Read More
SEC Charges Investment Adviser and Its Principals with Fraud OriginalRead More
Ellen Cooper assumes the role of president and CEO ofRead More
NEWPORT NEWS, Va., May 27, 2022 — With HII-built aircraftRead More
The Securities and Exchange Commission today announced that Investor AdvocateRead More
Global menstrual health and hygiene programs benefitted 8.7 million peopleRead More
General Motors announced today Marcos Purty will be appointed viceRead More
The Union of European Football Associations (UEFA) Champions League FinalRead More
SAN FRANCISCO , May 27, 2022 /PRNewswire/ — Autodesk, Inc.Read More
Addition to the S&P BSE IPO Index Original Source